Adjuvant chemotherapy and outcomes in patients with nodal and resection margin-negative pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
- PMID: 30838647
- DOI: 10.1002/jso.25440
Adjuvant chemotherapy and outcomes in patients with nodal and resection margin-negative pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
Abstract
Adjuvant chemotherapy (AC) following pancreatic carcinoma (PC) resection improves overall survival (OS). A systematic review identified 10 phase-2/3 studies investigating AC in 3644 patients looking at the influence of nodal and resection status. AC significantly improved disease free survival, OS and 5-year odds of death risk. There was greater survival benefit in patients PS 0 and with body/tail tumors. There was a nonsignificant effect in N - /N + patients on OS and no difference between R0/R1 patients.
Keywords: adjuvant chemotherapy; lymph nodes; meta-analysis; pancreatic cancer; resection margin; systematic review.
© 2019 Wiley Periodicals, Inc.
Comment in
-
Response to letter to the editor: The impact of the nodal status and resection margin on the effectiveness of adjuvant chemotherapy for pancreatic cancer: It calls for more careful evaluation.J Surg Oncol. 2019 Nov;120(6):1055. doi: 10.1002/jso.25691. Epub 2019 Aug 30. J Surg Oncol. 2019. PMID: 31471897 No abstract available.
-
The impact of the nodal status and resection margin on the effectiveness of adjuvant chemotherapy for pancreatic cancer: It calls for more careful evaluation.J Surg Oncol. 2019 Nov;120(6):1053-1054. doi: 10.1002/jso.25690. Epub 2019 Aug 30. J Surg Oncol. 2019. PMID: 31471900 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
